Related Tags >> FDA Clinical Trial Phase II Phase III

osteoarthritis News

Most Popular osteoarthritis Story

NicOx shares plunge on Pfizer trial failure

May 6, 2008 — 5:59am ET

Shares of France's NicOx tumbled 38 percent after Pfizer announced that it would not advance their Read more...

osteoarthritis Press Releases

BioChemics Announces Positive Phase 2 Data for a Novel Transdermal Ibuprofen Drug Formulation Developed to Treat Osteoarthritis
BioChemics Announces Positive Phase 2 Data for a Novel Transdermal Ibuprofen Drug Formulation Developed to Treat Osteoarth
Osteoarthritis Finding Could Pave Way for Prevention
Osteoarthritis Finding Could Pave Way for Prevention
Geron Announces Conference Call to Discuss Second Quarter Financial Results and Highlights

Latest Headlines

S. Korean biotech snags financing with help from U.S. venture group
January 13, 2012
Anika shares skyrocket on Canadian drug approval
August 20, 2009
NicOx shares plunge on Pfizer trial failure
May 6, 2008
Emisphere chief sees plenty of new potential for technology
March 20, 2008
Pfizer grabs osteoarthritis therapy in $250M deal
January 16, 2008
ALSO NOTED: Osiris shares jump on therapy results; Genmab recruits patients for leukemia study; Biocompatibles to launch stem c
November 28, 2007
ALSO NOTED: NicOx posts positive osteoarthritis data; Genzyme snares diagnostics unit; Infinity regains program rights; and muc
November 12, 2007
ALSO NOTED: Schering-Plough touts trial; Novartis pain therapy wins approval; New study for HIV vaccine; and much more...
October 22, 2007
Press Release: Genzyme Corporation's Hylastan Misses Goal in Arthritis Trial
July 5, 2007
SPOTLIGHT: GSK expands pact with Galapagos
July 1, 2007
ALSO NOTED: Omeros gets new funding; Positive data released on Fentora; Pfizer inks RNAi deal with Mirus;and much more...
January 9, 2007
Press Release: FivePrime Enters Osteoarthritis and Pulmonary Fibrosis Collaboration With Centocor
January 3, 2007
FivePrime scores $15M in collaboration pact
January 2, 2007
Cardiologists slam Merck on Arcoxia data
November 12, 2006
Release: NicOx receives FDA feedback that no cardiovascular outcomes study required for naproxcinod NDA
November 9, 2006
ALSO NOTED: MedImmune sells CytoGam; Targacept reports mixed data; and much more...
November 8, 2006
CombinatoRx surges on positive Phase II data
November 5, 2006
ALSO NOTED: Europe expands Synvisc approval; FDA issues "approvable" letter for paliperidone; and much more...
October 1, 2006
SPOTLIGHT: Galapagos inks deal with GSK
June 6, 2006
DOV drug flunks its Phase III pain test
April 24, 2006

Paid Research Reports

More Research Reports >>